Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a

Jeffrey D. Calhoun, Nicole Alise Hawkins, Nicole J. Zachwieja, Jennifer A Kearney*

*Corresponding author for this work

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

More than 1,200 mutations in neuronal voltage-gated sodium channel (VGSC) genes have been identified in patients with several epilepsy syndromes. A common feature of genetic epilepsies is variable expressivity among individuals with the same mutation. The Scn2aQ54 transgenic mouse model has a mutation in Scn2a that results in spontaneous epilepsy. Scn2aQ54 phenotype severity varies depending on the genetic strain background, making it a useful model for identifying and characterizing epilepsy modifier genes. Scn2aQ54 mice on the [C57BL/6JxSJL/J]F1 background exhibit earlier seizure onset, elevated spontaneous seizure frequency, and decreased survival compared to Scn2aQ54 mice congenic on the C57BL/6J strain. Genetic mapping and RNA-Seq analysis identified Cacna1g as a candidate modifier gene at the Moe1 locus, which influences Scn2aQ54 phenotype severity. In this study, we evaluated the modifier potential of Cacna1g, encoding the Cav3.1 voltage-gated calcium channel, by testing whether transgenic alteration of Cacna1g expression modifies severity of the Scn2aQ54 seizure phenotype. Scn2aQ54 mice exhibited increased spontaneous seizure frequency with elevated Cacna1g expression and decreased seizure frequency with decreased Cacna1g expression. These results provide support for Cacna1g as an epilepsy modifier gene and suggest that modulation of Cav3.1 may be an effective therapeutic strategy.

Original languageEnglish (US)
Pages (from-to)e103-e107
JournalEpilepsia
Volume57
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Voltage-Gated Sodium Channels
Modifier Genes
Epilepsy
Seizures
Mutation
Phenotype
Congenic Mice
Calcium Channels
Inbred C57BL Mouse
Transgenic Mice
RNA
Survival
Genes

Keywords

  • Genetics
  • Mouse model
  • Seizures
  • Voltage-gated calcium channels
  • Voltage-gated ion channels

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{d52cd8ed34e44095af6a29fb1dd774d9,
title = "Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a",
abstract = "More than 1,200 mutations in neuronal voltage-gated sodium channel (VGSC) genes have been identified in patients with several epilepsy syndromes. A common feature of genetic epilepsies is variable expressivity among individuals with the same mutation. The Scn2aQ54 transgenic mouse model has a mutation in Scn2a that results in spontaneous epilepsy. Scn2aQ54 phenotype severity varies depending on the genetic strain background, making it a useful model for identifying and characterizing epilepsy modifier genes. Scn2aQ54 mice on the [C57BL/6JxSJL/J]F1 background exhibit earlier seizure onset, elevated spontaneous seizure frequency, and decreased survival compared to Scn2aQ54 mice congenic on the C57BL/6J strain. Genetic mapping and RNA-Seq analysis identified Cacna1g as a candidate modifier gene at the Moe1 locus, which influences Scn2aQ54 phenotype severity. In this study, we evaluated the modifier potential of Cacna1g, encoding the Cav3.1 voltage-gated calcium channel, by testing whether transgenic alteration of Cacna1g expression modifies severity of the Scn2aQ54 seizure phenotype. Scn2aQ54 mice exhibited increased spontaneous seizure frequency with elevated Cacna1g expression and decreased seizure frequency with decreased Cacna1g expression. These results provide support for Cacna1g as an epilepsy modifier gene and suggest that modulation of Cav3.1 may be an effective therapeutic strategy.",
keywords = "Genetics, Mouse model, Seizures, Voltage-gated calcium channels, Voltage-gated ion channels",
author = "Calhoun, {Jeffrey D.} and Hawkins, {Nicole Alise} and Zachwieja, {Nicole J.} and Kearney, {Jennifer A}",
year = "2016",
month = "6",
day = "1",
doi = "10.1111/epi.13390",
language = "English (US)",
volume = "57",
pages = "e103--e107",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "6",

}

Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a. / Calhoun, Jeffrey D.; Hawkins, Nicole Alise; Zachwieja, Nicole J.; Kearney, Jennifer A.

In: Epilepsia, Vol. 57, No. 6, 01.06.2016, p. e103-e107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a

AU - Calhoun, Jeffrey D.

AU - Hawkins, Nicole Alise

AU - Zachwieja, Nicole J.

AU - Kearney, Jennifer A

PY - 2016/6/1

Y1 - 2016/6/1

N2 - More than 1,200 mutations in neuronal voltage-gated sodium channel (VGSC) genes have been identified in patients with several epilepsy syndromes. A common feature of genetic epilepsies is variable expressivity among individuals with the same mutation. The Scn2aQ54 transgenic mouse model has a mutation in Scn2a that results in spontaneous epilepsy. Scn2aQ54 phenotype severity varies depending on the genetic strain background, making it a useful model for identifying and characterizing epilepsy modifier genes. Scn2aQ54 mice on the [C57BL/6JxSJL/J]F1 background exhibit earlier seizure onset, elevated spontaneous seizure frequency, and decreased survival compared to Scn2aQ54 mice congenic on the C57BL/6J strain. Genetic mapping and RNA-Seq analysis identified Cacna1g as a candidate modifier gene at the Moe1 locus, which influences Scn2aQ54 phenotype severity. In this study, we evaluated the modifier potential of Cacna1g, encoding the Cav3.1 voltage-gated calcium channel, by testing whether transgenic alteration of Cacna1g expression modifies severity of the Scn2aQ54 seizure phenotype. Scn2aQ54 mice exhibited increased spontaneous seizure frequency with elevated Cacna1g expression and decreased seizure frequency with decreased Cacna1g expression. These results provide support for Cacna1g as an epilepsy modifier gene and suggest that modulation of Cav3.1 may be an effective therapeutic strategy.

AB - More than 1,200 mutations in neuronal voltage-gated sodium channel (VGSC) genes have been identified in patients with several epilepsy syndromes. A common feature of genetic epilepsies is variable expressivity among individuals with the same mutation. The Scn2aQ54 transgenic mouse model has a mutation in Scn2a that results in spontaneous epilepsy. Scn2aQ54 phenotype severity varies depending on the genetic strain background, making it a useful model for identifying and characterizing epilepsy modifier genes. Scn2aQ54 mice on the [C57BL/6JxSJL/J]F1 background exhibit earlier seizure onset, elevated spontaneous seizure frequency, and decreased survival compared to Scn2aQ54 mice congenic on the C57BL/6J strain. Genetic mapping and RNA-Seq analysis identified Cacna1g as a candidate modifier gene at the Moe1 locus, which influences Scn2aQ54 phenotype severity. In this study, we evaluated the modifier potential of Cacna1g, encoding the Cav3.1 voltage-gated calcium channel, by testing whether transgenic alteration of Cacna1g expression modifies severity of the Scn2aQ54 seizure phenotype. Scn2aQ54 mice exhibited increased spontaneous seizure frequency with elevated Cacna1g expression and decreased seizure frequency with decreased Cacna1g expression. These results provide support for Cacna1g as an epilepsy modifier gene and suggest that modulation of Cav3.1 may be an effective therapeutic strategy.

KW - Genetics

KW - Mouse model

KW - Seizures

KW - Voltage-gated calcium channels

KW - Voltage-gated ion channels

UR - http://www.scopus.com/inward/record.url?scp=84964598906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964598906&partnerID=8YFLogxK

U2 - 10.1111/epi.13390

DO - 10.1111/epi.13390

M3 - Article

C2 - 27112236

AN - SCOPUS:84964598906

VL - 57

SP - e103-e107

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 6

ER -